Journal of Clinical Oncology
Research Hotspot & Journal Scope - treated
RELAY: A multinational, double-blind, randomized Phase 3 study of erlotinib (ERL) in combination with ramucirumab (RAM) or placebo (PL) in previously untreated patients with epidermal growth factor receptor mutation-positive (EGFRm) metastatic non-small cell lung cancer (NSCLC).
Kazuhiko Nakagawa · Edward B. Garon · Takashi Seto · Makoto Nishio · Santiago Ponce Aix · Chao-Hua Chiu · Keunchil Park · Silvia Novello · Ernest Nadal · Fumio Imamura · Kiyotaka Yoh · Jin-Yuan Shih · Kwok Hung Au · Denis Moro-Sibilot · Sotaro Enatsu · Annamaria Zimmermann · Bente Frimodt-Moller · Carla M. Visseren Grul · Martin Reck ·
MedicineAlterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (IO) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts).
Yasser Ged · Joshua Chaim · Andrea Knezevic · Maria I. Carlo · Ashley Foster · Darren R. Feldman · Min Yuen Teo · Nadeem Riaz · Chung-Han Lee · Sujata Patil · Timothy A. Chan · A. Ari Hakimi · Robert J. Motzer · Martin H. Voss ·
MedicineReal-world outcomes of underrepresented patient populations treated with immune checkpoint inhibitors (ICIs): African American descent, poor ECOG performance status, and chronic viral infections.
Neil J. Shah · Matthew Blackburn · Michael R. Cook · Anas Belouali · Michael Serzan · William J Kelly · Athanasios Bikas · Chul Kim · Subha Madhavan · Stephen V. Liu · Michael B. Atkins ·
MedicinePrimary results of the phase 4 BYOND study of bosutinib (BOS) for pretreated chronic phase (CP) chronic myeloid leukemia (CML).
Carlo Gambacorti-Passerini · Camille N. Abboud · Bjørn Tore Gjertsen · Tim H. Brümmendorf · B. Douglas Smith · Pilar Giraldo-Castellano · Ulla Olsson-Strömberg · Susanne Saussele · Nathalie Bardy-Bouxin · Andrea Viqueira · Eric Leip · Jocelyn M Leone · Gianantonio Rosti · Justin M. Watts · Frank Giles · Andreas Hochhaus · Byond Study Investigators ·
MedicineIn-depth gene expression analysis of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with ribociclib-containing therapy in the Phase III MONALEESA-7 trial.
Yen-Shen Lu · Sara A. Hurvitz · Fei Su · Wei He · Debu Tripathy · Saul Campos Gomez · Kyung Hae Jung · Marco Colleoni · Paul Wheatley-Price · Sherko Kuemmel · Nadia Harbeck · F. Franke · Seock-Ah Im · Louis W.C. Chow · Tetiana Taran · Karen Rodriguez-Lorenc · Naveen Babbar · Aditya Bardia ·
MedicineScientific Writng Examples of Hematoma Treated in a Sentence
Objective: Functional outcome of the patients with acute subdural hematoma treated surgically within 4 hrs.
Scientific Writng Examples of Heifers Treated in a Sentence
Heifers treated with BXKM had Hp concentrations lower than SPAY heifers at 2 d (P = 0.
Scientific Writng Examples of People Treated in a Sentence
,One paper reported on outcomes after an average of 20 years for people treated with Open Dialogue approach compared with usual treatment in Finland.
Scientific Writng Examples of Hemangioma Treated in a Sentence
Methods The clinical data of 48 patients with hepatic hemangioma treated at our hospital from July, 2016 to June, 2018 were collected, and were randomly divided into a control group and a combined group, 24 cases for each group.
Scientific Writng Examples of Palate Treated in a Sentence
Method: A 13-year and 3-month-old girl, with moderately severe conductive bilateral hearing loss diagnosed with BOFS, presented: bilateral cleft lip and palate treated by labioplasty and palatoplasty, facial asymmetry, anterior maxillary fistula, transverse maxillary atresia, imperfect dentinogenesis, negative horizontal trespass, Angle Class I bilateral, anterior and lateral open bite on both sides, severe left superior midline deviation, eruption by vestibular of the superior canine on the left side, prolonged retention of the second inferior molar right deciduous, lower dental crowding, hypotonia and inadequate tongue positioning, absence of labial resting at rest, adapted swallowing, alteration in mobility of lips, cheeks and palate with nasal air exhaust in speech, characterizing velopharyngeal dysfunction.